Lymph fluid study could unlock new clues about multiple sclerosis
NCT ID NCT05162638
First seen Jan 11, 2026 · Last updated Apr 28, 2026 · Updated 18 times
Summary
This study collects lymph fluid from the chest of 24 people (some with multiple sclerosis, some healthy) to compare immune cells. Researchers want to understand how the immune system behaves in MS and how an approved MS drug (ofatumumab) changes those cells. The goal is to learn more about the disease, not to provide direct treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
Conditions
Explore the condition pages connected to this study.